
Childhood asthma is a scary healthy issue, for both child and parents alike. While proper diagnosis and treatment can help keep the condition from spiralling out of control, frequent asthma-related trips to the emergency room are a fact of life for many. An estimated 9 million children in the U.S. are affected by asthma, a condition brought on by food and air-borne allergens. Finding and controlling the triggers for asthma attacks is a priority, and a team of researchers from Glasgow University of Scotland now believe that the incidence of asthma is directly reflected in the number of hours young children watch TV each day.
April 23, 2007 -- A stomach bacterium that causes ulcers and is linked to stomach cancer may make asthma less likely.
by Erwin W. Gelfand, MD
Scientists have identified a gene that could lead to a breakthrough in the treatment of asthma, with tablets replacing steroid inhalers.
A study led by Adnan Custovic from the University of Manchester analyzing two surveys ten years apart (1993 and 2003) among 9-16 yr old schoolchildren attending urban and rural schools in Ghana showed that the prevalence of both exercise-induced bronchospasm and atopy had approximately doubled over the period.
A fresh study by the Environmental Health section of the National Public Health Institute shows a strong link between asthma in children and dampness in the building structures of the home.
Researchers have long noted that many asthma sufferers also have atopic dermatitis -- often called eczema -- a chronic disease of the skin that can leave it red, raw, scaly, tender, oozy and excruciatingly itchy. But scientists are looking at whether such ravaging of the skin creates the conditions that can trigger asthma.
DUBLIN, Ireland--(BUSINESS WIRE)--
February 16, 2007 — In children with intermittent asthma, a short course of montelukast resulted in reduction in acute healthcare resources, asthma symptoms, and days lost from school and from work for parents, according to the results of a multicenter, randomized, double-blind, controlled trial reported in the February 15 issue of the American Journal of Respiratory & Critical Care Medicine.
AstraZeneca today announced that 37 countries to date have received approval of Symbicort® Maintenance And Reliever Therapy (Symbicort SMART®), and that a period of world wide launches will now be initiated. This new, smarter approach to asthma is the first to provide patients with both asthma maintenance and reliever therapy together in just one inhaler.
Purpose of review: There is evidence for an association between asthma and air pollutants, including ozone, NO2 and particulate matter. Since these pollutants are ubiquitous in the urban atmosphere and typically correlated with each other it has been difficult to ascertain the specific sources of air pollution responsible for the observed effects.